.jpg)
.png)
2021 Industry Partner Support
EFF would like to thank the following industry partners for supporting our 2021 educational programming.
- AstraZeneca for unrestricted grants for the Seventh Annual Forum on Diabetes, Obesity, and Metabolism
- Medtronic for unrestricted grants for the Seventh Annual Forum on Diabetes, Obesity, and Metabolism
- Amgen for unrestricted grants for the Metabolic Bone Disease Preceptorship at Columbia University
- Radius for unrestricted grants for the Metabolic Bone Disease Preceptorship at Columbia University
- Amgen for unrestricted grants for the EFF and ASBMR Fellows Forum on Metabolic Bone Diseases
- ASBMR for unrestricted grants for the EFF and ASBMR Fellows Forum on Metabolic Bone Diseases
- NIAMS for unrestricted grants for the EFF and ASBMR Fellows Forum on Metabolic Bone Diseases
- AstraZeneca for unrestricted grants for the Endocrine Fellows Research Grant Program
- Medtronic for unrestricted grants for the Endocrine Fellows Research Grant Program
- Merck & Co. for unrestricted grants for the Endocrine Fellows Research Grant Program
Endocrine Fellows Foundation
.png "Human Bones")
Our Vision
EFF is an organization dedicated to the career development of fellows in training and nascent young investigators. Our vision is through preceptorships, symposiums, and research grant support. We support trainees in endocrinology to further advance their career goals and to strengthen our subspecialty.
Our Goals
Enhancing the knowledge base addressing emerging content areas during the fellowship training period. Fostering new thought leader development to address current and future gaps in endocrinology, diabetes, and metabolism. Bridging the gap between the completion of a fellowship program and a future career in academia, research, or clinical practice.
EFF Programs
Diabetes Research Forum
A Continuing Medical Education Program for Junior Faculty and Fellows organized in conjunction with Northwestern University Feinberg School of Medicine. Fellows present their fellowship projects to experts of the field who provide feedback and valuable critiques. Expert faculty also present on trending topics in Diabetes.
Diabetes Mellitus Preceptorship
Held at the Naomi Berrie Diabetes Center at Columbia University the program exposes fellows to a diverse scope of diabetes mellitus research initiatives and cutting-edge clinical, diagnostic and therapeutic approaches. Fellows gain valuable insight from the faculty’s experience in a vigorous clinical research program as well as in an active practice.
Metabolic Bone Disease Preceptorship
Held at the Columbia University Medical Center, Division of Endocrinology the program provides fellows an in-depth exposure to metabolic bone diseases through clinical case discussions, journal club, and research seminars. The discipline of clinical investigation is introduced along with individual tutorials on protocol design, acquisition, interpretation of data, and statistical testing.
Forum on Metabolic Bone Diseases
Held in conjunction with the ASBMR Annual Meeting the program engages fellows training in osteoporosis and other metabolic bone diseases in the United States and International programs. The intensive forum of plenary lectures, breakout sessions and poster presentations combined with the ASBMR Annual Meeting offers a unique learning opportunity.
Get Connected with the EFF Community!
Fellows Spotlight
Reilly Coch MD MPHEndocrinology and Diabetes, Cayuga Medical CenterInstructor in Clinical Medicine, Weill Cornell Medicine
Congratulations to Dr. Coch for the publication of her EFF-funded study in the American Diabetes Association's Diabetes Journal. The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition Additionally she is starting a pilot study of glucagon infusion in dogs at the Cornell Veterinary School and hopes to repeat the study in humans at Weill-Cornell Medical School in the coming years.
Congratulations to Dr. Coch for the publication of her EFF-funded study in the American Diabetes Association's Diabetes Journal. The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition Additionally she is starting a pilot study of glucagon infusion in dogs at the Cornell Veterinary School and hopes to repeat the study in humans at Weill-Cornell Medical School in the coming years.
Fellows Spotlight
Joseph M. Kindler PhDAssistant Professor, Department of Foods and Nutrition
University of Georgia
Dr. Joseph Kindler has accepted a tenure-track Assistant Professor position in the Department of Foods and Nutrition at the University of Georgia (Athens, Georgia USA). In this role, Dr. Kindler will teach undergraduate and graduate level courses in nutrition, and will continue his clinical and translational research program involving determinants of peak bone mass. Notably, he intends to build upon his American Diabetes Association and Endocrine Fellows Foundation-funded research aimed at understanding the influence of type 2 diabetes on the growing skeleton. Click here to read more about Dr. Kindler's work.
Dr. Joseph Kindler has accepted a tenure-track Assistant Professor position in the Department of Foods and Nutrition at the University of Georgia (Athens, Georgia USA). In this role, Dr. Kindler will teach undergraduate and graduate level courses in nutrition, and will continue his clinical and translational research program involving determinants of peak bone mass. Notably, he intends to build upon his American Diabetes Association and Endocrine Fellows Foundation-funded research aimed at understanding the influence of type 2 diabetes on the growing skeleton. Click here to read more about Dr. Kindler's work.
.jpg)
.jpg "NIH")
